Annamaria Szabolcs Selected Research

Annamaria Szabolcs Research Topics

Disease

8	Neoplasms (Cancer) 01/2022 - 01/2011
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2011
4	Adenocarcinoma 01/2022 - 01/2013
3	Virus Diseases (Viral Diseases) 01/2022 - 08/2020
3	COVID-19 01/2021 - 08/2020
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 03/2011
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 11/2021
2	Breast Neoplasms (Breast Cancer) 12/2020 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2020
2	Body Weight (Weight, Body) 01/2006 - 02/2005
2	Pancreatitis 01/2006 - 02/2005
1	Ovarian Epithelial Carcinoma 01/2022
1	Brain Neoplasms (Brain Tumor) 12/2020
1	Hypoxia (Hypoxemia) 12/2020
1	Circulating Neoplastic Cells 01/2020
1	Pathologic Processes 10/2010
1	Chronic Pancreatitis 03/2007
1	Acute Necrotizing Pancreatitis 01/2006

Drug/Important Bio-Agent (IBA)

8	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2019
4	Proteins (Proteins, Gene)FDA Link 12/2020 - 01/2020
3	InterferonsIBA 01/2022 - 08/2020
3	Pharmaceutical PreparationsIBA 12/2020 - 01/2011
2	Cetuximab (Erbitux)FDA Link 01/2013 - 01/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2007 - 02/2005
2	Amylases FDA Link 01/2006 - 02/2005
2	Peroxidase (Myeloperoxidase)IBA 01/2006 - 02/2005
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Nucleic AcidsIBA 01/2022
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022
1	DNA Transposable Elements (Element, IS)IBA 01/2022
1	Reverse Transcriptase InhibitorsIBA 01/2022
1	ElementsIBA 01/2022
1	NucleosidesIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 11/2021
1	Viral ProteinsIBA 01/2021
1	Coloring Agents (Dyes)IBA 01/2021
1	Viral RNAIBA 01/2021
1	Small Interfering RNA (siRNA)IBA 12/2020
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2020
1	folfirinoxIBA 12/2019
1	GoldIBA 01/2013
1	Gemcitabine FDA Link 01/2013
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 01/2013
1	4-nitrobenzylthioinosineIBA 01/2013
1	CaspasesIBA 03/2011
1	Cisplatin (Platino)FDA LinkGeneric 03/2011
1	Monoclonal AntibodiesIBA 01/2011
1	NanoconjugatesIBA 01/2011
1	ErbB Receptors (EGF Receptor)IBA 01/2011
1	Transforming Growth Factor beta (TGF-beta)IBA 10/2010
1	CytokinesIBA 03/2007
1	Interleukin-8 (Interleukin 8)IBA 03/2007
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 03/2007
1	Interleukin-6 (Interleukin 6)IBA 01/2006
1	AntioxidantsIBA 01/2006
1	Superoxide Dismutase-1IBA 01/2006
1	Arginine (L-Arginine)FDA Link 01/2006
1	CatalaseIBA 01/2006
1	EnzymesIBA 01/2006
1	MelatoninIBA 01/2006
1	Transcription Factors (Transcription Factor)IBA 02/2005
1	Peptides (Polypeptides)IBA 02/2005
1	NF-kappa B (NF-kB)IBA 02/2005
1	Glutathione (Reduced Glutathione)IBA 02/2005
1	Cholecystokinin (Pancreozymin)IBA 02/2005
1	Sincalide FDA Link 02/2005

Therapy/Procedure

5	Therapeutics 01/2020 - 01/2006
2	Precision Medicine 01/2022 - 01/2020
2	Injections 12/2020 - 01/2006
1	Immunotherapy 11/2021
1	Radiotherapy 11/2021
1	Combination Drug Therapy (Combination Chemotherapy) 12/2019
1	Drug Therapy (Chemotherapy) 03/2011
1	Aftercare (After-Treatment) 02/2005